Reviewer For Pedia Osce: 10.5 KG 45.16 CM / 17.8 in 75 CM Six
Reviewer For Pedia Osce: 10.5 KG 45.16 CM / 17.8 in 75 CM Six
Reviewer For Pedia Osce: 10.5 KG 45.16 CM / 17.8 in 75 CM Six
HEAD CIRCUMFERENCE
Age Inches Centimeters
At Birth 13.8 in 35 cm
< 4 mo + 2 in (1/2 inches / mo) + 5.08cm (1.27cm / mo)
5-12 mo + 2 in (1/4 inches / mo) + 5.08cm (0.635cm / mo)
1-2 yrs + 1 inch 2.54 cm
3-5 yrs + 1.5 in (1/2 inches / year) + 3.81cm (1.27cm / yr) 12. Extremities
6-20 yrs + 1.5 in (1/2 inches / 5 years) + 3.81cm (1.27cm / 5 yrs) - Syndactyly? Polydactyly?
- Simian crease?
NEWBORN CARE - Clubfoot?
Physical Examination of the Newborn 13. Trunk and Spine
1. Skin - Abnormal pigmentation? Hairy patches?
- Color (Plethoric? Jaundice? Pallor? Cyanosis?) - Sacral dimpling?
- Mottling? 14. Anus and Rectum
- Vernix caseosa? - Patency
- Rashes and Birthmarks 15. Nervous System
2. Head - muscle activity and tone?
- Note the general shape of the head
o Caput succedaneum PERFORM THE FOLLOWING:
o Cephalhematoma • Ophthalmic Antibiotic Ointment
o Molding - Prevents ophthalmia neonatorum)
- Inspect for any cuts, bruises secondary to forceps or fetal monitor - Wipe the eyes
leads - Apply an eye antimicrobial (Erythromycin) within 1 hour of birth
- Check the size of the head (microcephalic? Macrocephalic?) • Vitamin K administration
- Fontanels (diamond-shaped anterior; triangular posterior) - Administer Vitamin K 0.5-1 mg IM upper outer quadrant (vastus
lateralis) of the thigh
- To prevent hemorrhagic disease of the newborn
• Took the weight (Average Filipino birth weight: 3 kg)
• Anthropometric measurements
o Birth length (N: 50 cm)
o Head circumference (N: 33-38 cm)
o Chest circumference
o Abdominal circumference
• Check the patency of the anus
• Check the temperature
• Assure proper temperature maintenance
NEWBORN SCREENING
CASE: A relative of a 48-hour neonate knocks at the door of the NICU asking
NEWBORN RESUSCITATION questions about newborn screening.
CASE: You were assigned to catch a baby at the NICU. On the first minute
of resuscitation, the baby is seen with blue extremities and pink body, HR of 1. What are the six conditions tested in NEWBORN SCREENING?
110, grimaces a bit with some flexion of extremities, and slow, irregular Enumerate and give at least 1 clinical manifestation of each.
respiration. Glucose-6-Phosphate Hemolytic anemia à jaundice, anemia,
Dehydrogenase Deficiency renal failure
1. What comprises your APGAR Score? Galactosemia Cataract; liver failure
a. Appearance Congenital Hypothyroidism Macroglossia; hypothermia; Puffy eyelids,
b. Pulse coarse hair, myxedema
c. Grimace
Congenital Adrenal Hyperplasia Virilized girls and failure to thrive
d. Activity
Phenylketonuria Mousy odor with mental retardation
e. Respiration
Maple Syrup Urine Disease sweet-smelling urine, seizure
2. Give the APGAR score: 6
3. How will you resuscitate the baby?
a. Provide warmth 2. This act is also known as the “Newborn Screening Act of 2004”
b. Position, clear airway Republic Act 9288
c. Dry, stimulate, reposition
d. Give O2 Presidential Proclamation No. 540 declares the first week of October of each
year as National Newborn Screening Week.
NEWBORN SCREENING TEST TREATMENT: (based on Dr. W. Santos’ lecture)
• Blood collected after 24 hours from birth Early Onset
• If infant is <24 hours old when specimen is collected, it must be repeated • In the initial treatment of neonatal sepsis it is best to begin
before 14 days old antimicrobial therapy with ampicillin or penicillin in combination
• The heel is the most frequently used site to collect a sample of blood with aminoglycoside. This combination is effective for the majority of
neonatal pathogens.
UMBILICAL CANNULATION Late Onset
Indications: • Vancomycin
- Vascular access (via UV) • Aminoglycoside
- Blood pressure monitoring (via UA) • Amphotericin B (for fungal)
- Blood gas monitoring (via UA) ü The duration of parenteral antibiotic therapy should be 10-14 days.
ü In the presence of meningitis, antibiotic treatment should be given for 14-21
Complications: infection, bleeding, hemorrhage, perforation of vessel;
days.
thrombosis with distal embolization; ischemia or infarction of lower extremities,
bowel, or kidney; arrhythmia if catheter is in the heart; air embolus NEONATAL JAUNDICE
Caution: UA catheterization should never be performed if omphalitis or peritonitis
is present. Contraindicated in the presence of possible necrotizing enterocolitis or
intestinal hypoperfusion
Line Placement:
a. Arterial Line: Low line vs high line
• Low line: The tip of the catheter should lie just above the aortic
bifurcation between L3 and L5
• High line: The tip of the catheter should be above the diaphragm
between T6 and T9
b. UV catheters should be placed in the inferior vena cava above the level of
the ductus venosus and the hepatic veins and below the level of the right Indirect Hyperbilrubinemia: Yellowish
atrium Direct Hyperbilirubinemia: Greenish
c. Catheter length: Determine the length of catheter required using either a
standardized graph or the regression formula. Add length for the height of PHYSIOLOGIC JAUNDICE PATHOLOGIC JAUNDICE
the umbilical stump • Onset ≥ 24 HOL usually on the 3rd day • Early onset < 24 HOL
• Standardized graph: determine the shoulder-umbilical length by of life • TSB increasing more than 5
measuring the perpendicular line dropped from the tip of the shoulder • TSB increasing less than 5 mg/kg/day mg/kg/day
to the level of the umbilicus • Decline to adult levels by the 10th to • TSB concentration exceeding 12.9
• Birth weight (BW) regression formula: 12th day of life mg/dL (FT) and >15 mg/dL (PT)
Low line: UA catheter length (cm) = BW (kg) + 7 • DSB > 2 mg/dL or 20% of TSB (total
High line: UA catheter length (cm) = [3 x BW (kg) + 9] serum bilirubin)
UV catheter length (cm) = [0.5 x high line UA (cm)] + 1 • Persists > 1 wk (FT) or >2 wks (PT)
Steps: [
DIAGNOSTICS:
• Culture from normal sterile sites: blood, CSF, urine
• CBC-PC with differentials
• C-reactive protein (CRP)
• Radiographs (CXR)
• Fluid Analyses: CSF
DIAPHRAGMATIC HERNIA DTaP/DTwP*
• Given IM
• 6 – 10 – 14 wk
• Min age: 6 weeks
• Min interval: 4 weeks
• 4th dose given as early as 12months of age, provided minimum interval of
6months from 3rd dose
• 5th dose 4th yr old (may not be given if 4th dose was administered at age 4
years or older)
*DTaP= diptheria and tetanus toxoids and acellular pertussis vaccine
DTwP= diptheria and tetanus toxoids and whole cell pertussis vaccine
OPV/IPV
• OPV given Per orem (PO) - 2 drops
• IPV given IM
• 6 – 10 – 14
IMMUNIZATION • Min age: 6 weeks
From Must-Know-Lecture... YOU MAY SKIP THIS and JUST STUDY THE TABLE ON THE NEXT PAGE... • Min interval: 4 weeks
Expanded Program of Immunization Vaccines of DOH Philippines (10) • Final dose: 4th birthday and at least 6months from previous dose
1. BCG vaccine • If 4 or more doses have been given prior to age 4 years, an additional dose
2. Hep B vaccine should be administered at age 4-6years
3. DTwP – Hib - HepB
4. OPV/ IPV HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE
5. Rotavirus vaccine • Given IM
6. Measles vaccine • 6w – 10w – 14w – 12month – 4yr
7. MMR vaccine • Min age: 6 weeks
8. PCV • Min interval: 4 weeks
9. Td • If 1st dose was given between 7-11months of age
– 2nd dose should be given at least 4 weeks later
Vaccines for Special Groups – 3rd dose at least 8 weeks from 2nd dose
1. JE vaccine • A Booster dose given 12-15months with an interval of 6 months from 3rd dose
2. Cholera vaccine • One dose should be considered for unimmunized children aged 5 year or older
3. Meningococcal vaccines (MCV4/ MPSV4) who have:
4. Typhoid Vaccine – Sickle cell disease
5. Rabies Vaccine – Leukemia
6. Penumococcal Vaccine (PCV/ PPV) – HIV
– Splenectomy
All infants should be immunized except in these three rare situations:
1. Anaphylaxis or a severe hypersensitivity reaction is an absolute ROTAVIRUS VACCINE
contraindication to subsequent doses of a vaccine. Persons with a known • Given per orem (PO)
allergy to a vaccine component should not be vaccinated. • 1st dose: 6 weeks of age
2. Do not give BCG or yellow fever vaccine to an infant who exhibits the • Last dose: not later than 32 weeks of Age
signs and symptoms of AIDS. Other vaccines should be given. • Monovalent Human Rotavirus Vaccine (RV1) given as 2 doses series
3. If a parent strongly objects to an immunization for a sick infant, do not • Pentavalent Human Bovine Rotavirus Vaccine (RV5) given as 3 doses series
give it. Ask the mother to come back when the infant is well. • Min interval: 4 weeks between doses
BACILLUS CALMETTE-GUERIN MEASLES VACCINE
• Intradermal (ID) • Given subcutaneously (SC)
• Earliest possible age after birth, preferably within the first 2 months of life • Age: 9 months
• For infants >2months who are healthy, PPD prior to BCG is not necessary • May be given as early as 6 months of age in cases of outbreaks
• PPD is recommended in infants > 2months prior to BCG if:
– Suspected congenital TB MMR VACCINE
– History of close contact to known or suspected infectious cases of TB • Given SC
– Clinical findings suggestive of TB • Min age: 12 months
– CXR suggestive of TB • 2 doses recommended
Note: PPD induration 5mm is POSITIVE • Children <12months of age given any measles containing vaccine (measles,
• Dose: MR, MMR) should be given 2 additional doses of MMR
– <12 months: 0.05ml – 1st dose 12-15months and should be separated by at least 4 weeks from
– >12 months: 0.1ml measles containing vaccine
– 2nd dose 4-6yrs (But may be administered at an earlier age provided the
HEPATITIS B VACCINE interval between 1st and 2nd is at least 4weeks)
• Given Intramuscular (IM) In EPI, 2nd dose of MMR given to public school students (13 yr old / 1st year high school)
• 0 – 4 – 10 – 14
• Min Age: birth PNEUMOCOCCAL VACCINE (PCV/ PPV)
• 1st dose should be given first 12 hours of life and counted as part of 3-dose • Given IM
primary series • 6 – 10 – 14 – 12months ++
• Subsequent doses are given at least 4 weeks apart • Min Age:
• 3rd dose preferably given >24 weeks of age – PCV: 6weeks
• 4th dose is needed if: – PPV: 2 years of age
– 3rd dose is given <24weeks • 1st vaccination PVC – 3 doses, interval 4 weeks + booster at 6 month after 3rd
– Preterm <2kg whose 1st dose given at birth dose
In EPI schedule, Hepa B is given as monovalent at birth then subsequent doses are given at • Healthy children 2-5 years old who have no previous PCV, may be given 1
6, 10, 14 weeks of age as combination vaccine containing DTwP/HepB/HiB
dose of PVC13 or 2 doses of PCV10, at least 8 weeks apart
• For healthy children, no additional doses of PPV are needed if the PCV series
Hepatitis B Vaccine in Newborn
is completed
• Preterm infants born to HBsAg(-) mothers who are medically stable
• For high risk children ≥2 years of age, PPV is recommended after completing
– may be given 1st dose of HBV @ 30days of chronologically age regardless
the PCV series (Special Groups)
of weight, counted as part of 3 dose primary series
• If Mother is HBsAg(+)
– HBV and HBIg should be given within 12hours of life
• If Mother HBsAg status is unknown
– Give HBV within 12hours
– Determine mother HBsAg as soon as possible
– If HBsAg(+) give HBIg no later than 7days of age
Min Min 3. What is the earliest time to request for urine culture, blood
Vaccine Route Site Dose Schedule
Age Interval culture, and stool culture?
Right 0.05 mL (<12m) a. Urine: after the first week
BCG ID At birth b. Blood: 40-60% first week
deltoid 0.1 mL (>12m)
Antero- c. Stool: after the first week
lateral 4. What drug can you give to this patient?
Hepa B IM 0.5 mL 0–4–10–14 Birth 4 wks Ceftriaxone
aspect of
thigh 5. At what dose will you give this drug?
Upper 50-100 mkD OD IV
outer 6. Give 3 complications of this disease
DPT IM 0.5 mL 6–10–14 6 wks 4 wks a. Intestinal perforation
aspect of
thigh b. Toxic encephalopathy
OPV PO Mouth 2 drops 6–10–14 6 wks 4 wks c. Toxic myocarditis
IPV IM 6–10–14 6 wks 4 wks
6w–10w– TREATMENT: (based on Dra. Cantimbuhan’s lecture)
HiB IM 6 wks 4 wks • Chloramphenicol: 50-100 mkD q6-q8 PO
14w-12m–4y
Rotavirus PO 6 wks 4 wks Alternative drugs:
Outer part • TMP-SMZ 8mg/k/D ÷ 2 doses X 14 days
Measles SC of upper 0.5 mL 9 mos • Amoxicillin 100mg/k/D PO ÷ 3 doses x 14 days
arm • Ampicillin 200 mg/k/D ÷ 4-6 doses x 14 days
MMR SC 12 mos 4 wks • Cefixime 15- 20 mkd for 7- 14 days
PCV IM 6 – 10 – 14 – 6 wks • Azithromycin 8-10 mkd for 7 days
PPV IM 12months ++ 2 yrs Suspected Resistant Strains :
From Dra. Tetangco’s lecture • Cefotaxime: 150 - 200 mg/k/d q hours
• Ceftriaxone: 100 mg/k/d OD x 5-7 days
• Ciprofloxacin: 20-30 mg/k/D ÷ 2 doses x 7-10 days
DENGUE FEVER
CASE: A 7-year old male came for consult at the ER with a chief complaint
of fever. History revealed 4-day fever, moderate to high-grade, associated
with anorexia, body malaise, and petechiae on abdomen and extremities.
PE: Findings showed irritable patient, (+) hepatomegaly with epigastric
tenderness, weak pulses, and cold clammy extremities. At present patient is
afebrile with BP = 100/90 mmHg.
DIARRHEAL DISEASES
KAWASAKI DISEASE
CLINICAL CRITERIA:
FEVER persisting at least 5 days or more PLUS presence of at least 4 or more of the
#CasesPaMore: principal features:
Cases Impression • Bilateral conjunctival injection without exudates
• Changes in the lips and oral cavity (Oropharyngeal)
9 months old; RR= 56 with chest indrawing PCAP C • Polymorphous exanthem
2 years old; RR= 50 with coarse crackles PCAP B • Changes in extremities
2 months old; RR= 50 Normal • Cervical lymphadenopathy (>1.5 cm in diameter)
6 months old; RR= 60 with central cyanosis and PCAP C
chest indrawing
1 month old; RR= 65 with chest indrawing Neonatal pneumonia, severe
ACUTE GLOMERULONEPHRITIS (AGN)
Refers to a variety of renal diseases characterized by sudden onset of:
ü Edema ü Hematuria – gross or ü Oligoanuria
significant microscopic
ü Hypertension ü Proteinuria ü Azotemia
In a previously well child
1. Diagnosis: Kawasaki Disease, Complete Type, in Acute Phase ALTERATIONS IN THE LEVEL OF CONSCIOUSNESS
2. Etiology: Unknown although clinical and epidemiological features CASE: A 7-year-old male came in at the ER with a 3-week history of high-
strongly suggest an infectious cause grade remittent fever. Patient was noted to be irritable 2 weeks prior and 1
3. Phase of the Clinical Course: Acute Phase hour prior to consult had 1 episode of seizure. On PE, patient is drowsy, eye
4. Complications: Giant aneurysm, Myocarditis opening upon painful stimuli, localizes pain, and moans. CT Scan revealed
calcifications on the basal cisterns, dilated ventricles with cerebral edema.
LUMBAR PUNCTURE
• technique of using a needle to withdraw cerebrospinal fluid (CSF) from the 1. GCS Score: E2V2M5 = 9
spinal canal 2. Impression: TB Meningitis
GCS
SPINE Function Infants/Young Older
• spinal cord stops near L2 Eye Opening 4- Spontaneous Spontaneous
• lower lumbar spine (usually between L3-L4 or L4–5) is preferable 3- To speech To speech
2- To pain To pain
CSF 1- None None
Verbal 5- Appropriate Oriented
• clear, watery liquid that protects the central nervous system from injury
4- Inconsolable Confused
• cushions the brain from the surrounding bone. 3- Irritable Inappropriate
• It contains: 2- Moans Incomprehensible
– glucose (sugar) 1- None None
– protein Motor 6- Spontaneous Spontaneous
– white blood cells 5- Localize pain Localize pain
• Rate: 500ml/day or 0.35ml/min 4- Withdraw Withdraw
3- Flexion Flexion
• Range: 0.3-0.4 ml/min 2- Extension Extension
• Volume: 50ml (infants); 150ml (adults) 1- None None
ADOLESCENT MEDICINE
HEADSSFIRST